• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种热稳定的喷雾干燥外膜囊泡百日咳疫苗用于肺部免疫接种。

Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.

机构信息

Intravacc (Institute for Translational Vaccinology), Bilthoven, The Netherlands; University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Groningen, The Netherlands.

Intravacc (Institute for Translational Vaccinology), Bilthoven, The Netherlands.

出版信息

J Control Release. 2018 Sep 28;286:167-178. doi: 10.1016/j.jconrel.2018.07.035. Epub 2018 Jul 24.

DOI:10.1016/j.jconrel.2018.07.035
PMID:30048656
Abstract

Worldwide resurgence of whooping cough calls for improved, next-generation pertussis vaccines that induce broad and long-lasting immunity. A mucosal pertussis vaccine based on outer membrane vesicles (omvPV) is a promising candidate. Further, a vaccine that is stable outside the cold chain would be of substantial advantage for worldwide distribution and application. A vaccine formulated as a powder could both stabilize the vaccine as well as make it suitable for pulmonary vaccination. To that end, we developed a spray dried omvPV with improved stability compared to the liquid omvPV formulation. Spray drying did not affect the structural integrity of the omvPV. The antigenicity of Vag8, a major antigen in omvPV was diminished slightly and an altered tryptophan fluorescence indicated some changes in protein structure. However, when administered via the pulmonary route in mice after reconstitution, spray dried omvPV showed comparable immune responses and protection against challenge with live B. pertussis as liquid omvPV. Mucosal IgA and Th17 responses were established in addition to broad systemic IgG and Th1/Th17 responses, indicating the induction of an effective immunity profile. Overall, a spray dried omvPV was developed that maintained effective immunogenic properties and has an improved storage stability.

摘要

全球百日咳卷土重来,需要改进下一代百日咳疫苗,以诱导广泛和持久的免疫力。基于外膜囊泡 (omvPV) 的粘膜百日咳疫苗是一种很有前途的候选疫苗。此外,对于全球分发和应用而言,一种在冷链之外稳定的疫苗将具有实质性的优势。制成粉末的疫苗既可以稳定疫苗,又可以使其适合肺部接种。为此,我们开发了一种喷雾干燥的 omvPV,与液体 omvPV 制剂相比,其稳定性得到了改善。喷雾干燥不会影响 omvPV 的结构完整性。 Vag8 是 omvPV 中的主要抗原,其抗原性略有降低,色氨酸荧光的改变表明蛋白质结构发生了一些变化。然而,当以干粉形式经肺部途径在小鼠中重新配制后,喷雾干燥的 omvPV 显示出与液体 omvPV 相当的免疫反应和对活 B. pertussis 挑战的保护作用。除了广泛的系统 IgG 和 Th1/Th17 反应外,还建立了粘膜 IgA 和 Th17 反应,表明诱导了有效的免疫状态。总的来说,开发了一种喷雾干燥的 omvPV,它保持了有效的免疫原性,并具有改善的储存稳定性。

相似文献

1
Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.开发一种热稳定的喷雾干燥外膜囊泡百日咳疫苗用于肺部免疫接种。
J Control Release. 2018 Sep 28;286:167-178. doi: 10.1016/j.jconrel.2018.07.035. Epub 2018 Jul 24.
2
Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.鼻内免疫百日咳外膜囊疫苗通过黏膜 IgA 和 Th17 应答提供广泛保护。
Sci Rep. 2020 Apr 30;10(1):7396. doi: 10.1038/s41598-020-63998-2.
3
Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.百日咳博德特氏菌外膜囊泡疫苗的免疫蛋白质组学分析揭示了广泛且平衡的体液免疫原性。
J Proteome Res. 2015 Jul 2;14(7):2929-42. doi: 10.1021/acs.jproteome.5b00258. Epub 2015 Jun 2.
4
Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine.百日咳博德特氏菌外膜囊泡疫苗在减轻炎症反应方面与全细胞疫苗等效,且在小鼠中具有同等效力。
Sci Rep. 2016 Dec 1;6:38240. doi: 10.1038/srep38240.
5
Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.在无细胞百日咳疫苗中添加Toll样受体7(TLR7)激动剂可增强小鼠模型中的Th1和Th17反应以及保护性免疫。
Vaccine. 2017 Sep 18;35(39):5256-5263. doi: 10.1016/j.vaccine.2017.08.009. Epub 2017 Aug 18.
6
Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.适应性免疫中 Th1 和 Th17 细胞的相对贡献:朝着改进无细胞百日咳疫苗的合理设计方向发展。
PLoS Pathog. 2013;9(4):e1003264. doi: 10.1371/journal.ppat.1003264. Epub 2013 Apr 4.
7
A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against , Including Pertactin Deficient Strains.百日咳外膜囊泡疫苗诱导肺部驻留记忆 CD4 T 细胞,并提供针对 的保护,包括无 pertactin 缺陷株。
Front Cell Infect Microbiol. 2019 Apr 26;9:125. doi: 10.3389/fcimb.2019.00125. eCollection 2019.
8
Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.基于生物膜培养衍生的外膜囊泡的百日咳疫苗候选物。
Front Immunol. 2021 Sep 15;12:730434. doi: 10.3389/fimmu.2021.730434. eCollection 2021.
9
Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.免疫原性和物理评估作为喷雾干燥粉末制剂的多阶段结核亚单位候选疫苗 H56/CAF01。
Vaccine. 2018 May 31;36(23):3331-3339. doi: 10.1016/j.vaccine.2018.04.055. Epub 2018 Apr 24.
10
A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.一种来自百日咳博德特氏菌的新型Toll样受体2(TLR2)激动剂是一种有效的佐剂,可促进无细胞百日咳疫苗的保护性免疫。
Mucosal Immunol. 2015 May;8(3):607-17. doi: 10.1038/mi.2014.93. Epub 2014 Oct 15.

引用本文的文献

1
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2.展示RBD的外膜囊泡纳米疫苗增强对SARS-CoV-2的免疫力。
J Nanobiotechnology. 2025 Feb 8;23(1):97. doi: 10.1186/s12951-025-03191-7.
2
Respiratory delivered vaccines: Current status and perspectives in rational formulation design.呼吸道给药疫苗:合理剂型设计的现状与展望
Acta Pharm Sin B. 2024 Dec;14(12):5132-5160. doi: 10.1016/j.apsb.2024.08.026. Epub 2024 Nov 4.
3
Insights into the unique roles of extracellular vesicles for gut health modulation: Mechanisms, challenges, and perspectives.
深入了解细胞外囊泡对肠道健康调节的独特作用:机制、挑战与展望。
Curr Res Microb Sci. 2024 Oct 21;7:100301. doi: 10.1016/j.crmicr.2024.100301. eCollection 2024.
4
Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery.细菌膜囊泡的喷雾干燥用于疫苗传递。
Methods Mol Biol. 2024;2843:163-175. doi: 10.1007/978-1-0716-4055-5_11.
5
Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.外膜囊泡作为发现针对细菌病原体抗体的平台。
Appl Microbiol Biotechnol. 2024 Feb 24;108(1):232. doi: 10.1007/s00253-024-13033-5.
6
In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines.基于外膜囊泡的疫苗的体外反应原性评估替代方法。
Sci Rep. 2023 Aug 4;13(1):12675. doi: 10.1038/s41598-023-39908-7.
7
Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model.铜绿假单胞菌 PAO1 外膜囊泡-白喉类毒素缀合物作为一种候选疫苗在小鼠烧伤模型中的应用。
Sci Rep. 2022 Dec 24;12(1):22324. doi: 10.1038/s41598-022-26846-z.
8
and outer membrane vesicles.以及外膜囊泡。
Pathog Glob Health. 2023 Jun;117(4):342-355. doi: 10.1080/20477724.2022.2117937. Epub 2022 Sep 1.
9
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.一种基于细菌细胞外囊泡的鼻腔内疫苗可预防 SARS-CoV-2 感染,诱导针对野生型和 Delta 变异株的中和抗体。
J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192.
10
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.一种基于细菌细胞外囊泡的抗SARS-CoV-2鼻内疫苗可预防疾病,并引发针对野生型和Delta变体的中和抗体。
bioRxiv. 2022 Feb 1:2021.06.28.450181. doi: 10.1101/2021.06.28.450181.